20,658 Shares in Cognex Corporation $CGNX Bought by New Age Alpha Advisors LLC

New Age Alpha Advisors LLC bought a new position in shares of Cognex Corporation (NASDAQ:CGNXFree Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 20,658 shares of the scientific and technical instruments company’s stock, valued at approximately $743,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. REAP Financial Group LLC acquired a new position in shares of Cognex during the third quarter worth $27,000. Geneos Wealth Management Inc. grew its stake in shares of Cognex by 402.2% during the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after purchasing an additional 736 shares in the last quarter. CIBC Private Wealth Group LLC grew its stake in shares of Cognex by 74.8% during the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock worth $35,000 after purchasing an additional 327 shares in the last quarter. Miller Global Investments LLC acquired a new position in shares of Cognex during the fourth quarter worth $39,000. Finally, Larson Financial Group LLC grew its stake in shares of Cognex by 202.7% during the fourth quarter. Larson Financial Group LLC now owns 1,105 shares of the scientific and technical instruments company’s stock worth $40,000 after purchasing an additional 740 shares in the last quarter. Institutional investors and hedge funds own 88.12% of the company’s stock.

Insider Activity

In other news, insider Mark Fennell sold 64,873 shares of the company’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $67.05, for a total value of $4,349,734.65. Following the completion of the sale, the insider directly owned 11,263 shares of the company’s stock, valued at approximately $755,184.15. This represents a 85.21% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Darren Marc Long sold 20,252 shares of the company’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the completion of the sale, the vice president directly owned 3,990 shares of the company’s stock, valued at $264,696.60. The trade was a 83.54% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 224,847 shares of company stock valued at $14,975,098. Insiders own 1.70% of the company’s stock.

Cognex Price Performance

NASDAQ CGNX opened at $66.01 on Friday. Cognex Corporation has a 1 year low of $29.22 and a 1 year high of $71.90. The company has a market capitalization of $10.99 billion, a PE ratio of 78.58 and a beta of 1.48. The company has a fifty day moving average of $56.65 and a two-hundred day moving average of $47.39.

Cognex (NASDAQ:CGNXGet Free Report) last released its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.09. Cognex had a net margin of 13.62% and a return on equity of 10.89%. The company had revenue of $268.44 million during the quarter, compared to the consensus estimate of $245.98 million. During the same quarter in the prior year, the firm posted $0.14 earnings per share. Cognex’s revenue for the quarter was up 24.3% on a year-over-year basis. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. On average, research analysts expect that Cognex Corporation will post 1.41 earnings per share for the current year.

Cognex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 4th. Stockholders of record on Thursday, May 21st will be issued a $0.085 dividend. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Thursday, May 21st. Cognex’s dividend payout ratio is presently 40.48%.

Analyst Ratings Changes

CGNX has been the subject of a number of analyst reports. Zacks Research downgraded shares of Cognex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 14th. Citigroup reiterated a “neutral” rating and set a $68.00 target price (up from $60.00) on shares of Cognex in a research note on Friday, May 8th. Seaport Research Partners set a $75.00 target price on shares of Cognex in a research note on Tuesday. JPMorgan Chase & Co. upgraded shares of Cognex from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $65.00 to $75.00 in a research note on Tuesday. Finally, Barclays restated an “overweight” rating and issued a $75.00 price objective (up from $64.00) on shares of Cognex in a research note on Monday, May 11th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, Cognex has a consensus rating of “Moderate Buy” and a consensus price target of $70.43.

Check Out Our Latest Analysis on Cognex

Cognex Company Profile

(Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

See Also

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNXFree Report).

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.